انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Episode 25. Managing Acute Toxicities of CAR T-cell Therapy
Manage episode 367350833 series 3369804
In this episode, we discuss the management of acute toxicities of CAR T-cell therapy, including CRS, ICANS, and HLH with Dr. Michael Jain from Moffitt Cancer Center.
Here are some of the key articles we discussed:
1. “How I treat refractory CRS and ICANS after CAR T-cell therapy”.
https://pubmed.ncbi.nlm.nih.gov/36989488/
2. CAR-HEMATOTOX score:
https://pubmed.ncbi.nlm.nih.gov/34166502/
3. “How I treat cytopenias after CAR T-cell therapy”.
https://pubmed.ncbi.nlm.nih.gov/36800563/
4. Immune Effector Cell-Associated HLH-Like Syndrome (ASTCT):
https://pubmed.ncbi.nlm.nih.gov/36906275/
5. ASTCT consensus grading for CRS and ICANS:
https://pubmed.ncbi.nlm.nih.gov/30592986/
6. Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy:
https://pubmed.ncbi.nlm.nih.gov/35696759/
7. Modified EASIX score for predicting CRS and neurotoxicity:
51 حلقات
Manage episode 367350833 series 3369804
In this episode, we discuss the management of acute toxicities of CAR T-cell therapy, including CRS, ICANS, and HLH with Dr. Michael Jain from Moffitt Cancer Center.
Here are some of the key articles we discussed:
1. “How I treat refractory CRS and ICANS after CAR T-cell therapy”.
https://pubmed.ncbi.nlm.nih.gov/36989488/
2. CAR-HEMATOTOX score:
https://pubmed.ncbi.nlm.nih.gov/34166502/
3. “How I treat cytopenias after CAR T-cell therapy”.
https://pubmed.ncbi.nlm.nih.gov/36800563/
4. Immune Effector Cell-Associated HLH-Like Syndrome (ASTCT):
https://pubmed.ncbi.nlm.nih.gov/36906275/
5. ASTCT consensus grading for CRS and ICANS:
https://pubmed.ncbi.nlm.nih.gov/30592986/
6. Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy:
https://pubmed.ncbi.nlm.nih.gov/35696759/
7. Modified EASIX score for predicting CRS and neurotoxicity:
51 حلقات
كل الحلقات
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.